ATYR Atyr Pharma Inc

Price (delayed)

$0.553

Market cap

$54.24M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.62

Enterprise value

$47.89M

?
Relative Growth: Rel. Growth: 11
Relative Strength: Rel. Strength: 20
Relative Valuation: Rel. Valuation: 1
Relative Profitability: Rel. Profitability: 30

Life Technologies Corporation (Life Technologies) is a global life sciences company. The Company's systems, consumables and services enable scientific researchers and commercial markets to accelerate scientific exploration, to discoveries and ...

Highlights
ATYR's EPS is up by 22% year-on-year and by 15% since the previous quarter
The net income has grown by 13% from the previous quarter and by 9% YoY
The company's equity fell by 35% YoY and by 16% QoQ
Atyr Pharma's quick ratio has decreased by 11% from the previous quarter and by 3.3% YoY

Key stats

What are the main financial stats of ATYR

ATYR stock price

How has the Atyr Pharma stock price performed over time
Intraday
2.35%
1 week
10.16%
1 month
9.7%
1 year
-89.26%
YTD
-29.38%
QTD
-7.34%

Financial performance

How have Atyr Pharma's revenue and profit performed over time
Revenue
$190,000
Gross profit
$190,000
Operating income
-$63.86M
Net income
-$60.81M
Gross margin
100%
Net margin
-32,003.7%
Atyr Pharma's operating income has increased by 13% from the previous quarter and by 9% YoY
The net income has grown by 13% from the previous quarter and by 9% YoY
The net margin has grown by 13% from the previous quarter
ATYR's operating margin is up by 13% since the previous quarter

Price vs fundamentals

How does ATYR's price correlate with its fundamentals

Growth

What is Atyr Pharma's growth rate over time

Valuation

What is Atyr Pharma stock price valuation
P/E
N/A
P/B
1.11
P/S
285.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
252.03
ATYR's EPS is up by 22% year-on-year and by 15% since the previous quarter
ATYR's P/B is 38% below its 5-year quarterly average of 1.8
The company's equity fell by 35% YoY and by 16% QoQ
ATYR's P/S is 22% below its last 4 quarters average of 365.6

Efficiency

How efficient is Atyr Pharma business performance
ATYR's ROS is up by 13% since the previous quarter
The company's return on invested capital rose by 5% QoQ
The ROA has grown by 5% from the previous quarter
The return on equity is up by 4.3% since the previous quarter but it has declined by 2.4% year-on-year

Dividends

What is ATYR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATYR.

Financial health

How did Atyr Pharma financials performed over time
The total assets has contracted by 31% YoY and by 12% from the previous quarter
ATYR's total liabilities is down by 21% year-on-year and by 3.1% since the previous quarter
The debt is 77% less than the equity
The company's equity fell by 35% YoY and by 16% QoQ
ATYR's debt to equity is up by 35% YoY and by 15% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.